Neoantigen cancer vaccine augments anti-CTLA-4 efficacy.
Salvatori E, Lione L, Compagnone M, Pinto E, Conforti A, Ciliberto G, Aurisicchio L, Palombo F.
Salvatori E, et al. Among authors: aurisicchio l.
NPJ Vaccines. 2022 Feb 2;7(1):15. doi: 10.1038/s41541-022-00433-9.
NPJ Vaccines. 2022.
PMID: 35110563
Free PMC article.